(Q73259715)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Altered expression of HLA class I antigens in breast cancer: association with prognosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

I Gudmundsdóttir

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Gunnlaugur Jónasson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Sigurdsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Olafsdóttir

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H M Ogmundsdóttir

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

500-505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Natural history of HLA expression during tumour development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

The immunology and immunotherapy of breast cancer: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Express yourself or die: peptides, MHC molecules, and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Correlation between tumour and serum beta 2m expression in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Antigen presentation: coming out gracefully

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Expression of class I histocompatibility antigens in transitional cell carcinoma of the urinary bladder in relation to survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Interactions between the immune system and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Effects of lymphocytes and fibroblasts on the growth of human mammary carcinoma cells studied in short-term primary cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

The interaction between beta 2-microglobulin (beta 2m) and purified class-I major histocompatibility (MHC) antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Expression of beta 2-microglobulin by premalignant epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Tumor immunogenicity: how far can it be pushed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Natural killer cells and recognition of MHC class I molecules: new perspectives and challenges in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

A new era for cancer immunotherapy based on the genes that encode cancer antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

β2-Microglobulin in non-malignant and malignant human breast: A feature of differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Indicators of prognosis in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820001120%2989%3A6%3C500%3A%3AAID-IJC6%3E3.0.CO%3B2-%23

10.1002/1097-0215(20001120)89:6<500::AID-IJC6>3.0.CO;2-#

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102894%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference